Steven Bondy

1.3k total citations
19 papers, 626 citations indexed

About

Steven Bondy is a scholar working on Molecular Biology, Hepatology and Infectious Diseases. According to data from OpenAlex, Steven Bondy has authored 19 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 6 papers in Hepatology and 4 papers in Infectious Diseases. Recurrent topics in Steven Bondy's work include Hepatitis C virus research (6 papers), HIV/AIDS drug development and treatment (4 papers) and Chemical Synthesis and Analysis (3 papers). Steven Bondy is often cited by papers focused on Hepatitis C virus research (6 papers), HIV/AIDS drug development and treatment (4 papers) and Chemical Synthesis and Analysis (3 papers). Steven Bondy collaborates with scholars based in United States, Belgium and Austria. Steven Bondy's co-authors include Charles G. Caldwell, Thomas E. Rollins, Salvatore Siciliano, Martin S. Springer, Julie A. DeMartino, Gail Van Riper, Lorraine Malkowitz, Zenon Konteatis, Hugh Rosen and Edward Sharman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and PLoS ONE.

In The Last Decade

Steven Bondy

19 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven Bondy United States 12 303 176 135 134 87 19 626
Jeffrey S. Culp United States 13 676 2.2× 117 0.7× 86 0.6× 115 0.9× 215 2.5× 15 1.3k
Jean Vizzavona France 12 466 1.5× 91 0.5× 110 0.8× 133 1.0× 134 1.5× 18 741
David L. Earnshaw United Kingdom 15 397 1.3× 66 0.4× 61 0.5× 62 0.5× 33 0.4× 21 849
Peggy Huang United States 11 470 1.6× 72 0.4× 37 0.3× 99 0.7× 45 0.5× 17 769
Maria Chiara Nardi Italy 11 613 2.0× 53 0.3× 77 0.6× 82 0.6× 14 0.2× 12 787
Thomas Stangler Germany 17 746 2.5× 222 1.3× 220 1.6× 75 0.6× 40 0.5× 25 1.1k
Carol A. Bannow United States 10 510 1.7× 52 0.3× 35 0.3× 98 0.7× 186 2.1× 16 909
Michele Tinti United Kingdom 16 885 2.9× 163 0.9× 57 0.4× 34 0.3× 16 0.2× 41 1.1k
Michael D. Minnich United States 10 246 0.8× 66 0.4× 22 0.2× 93 0.7× 161 1.9× 15 481
Abbas Rashidbaigi United States 15 326 1.1× 337 1.9× 149 1.1× 48 0.4× 6 0.1× 35 753

Countries citing papers authored by Steven Bondy

Since Specialization
Citations

This map shows the geographic impact of Steven Bondy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Bondy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Bondy more than expected).

Fields of papers citing papers by Steven Bondy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Bondy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Bondy. The network helps show where Steven Bondy may publish in the future.

Co-authorship network of co-authors of Steven Bondy

This figure shows the co-authorship network connecting the top 25 collaborators of Steven Bondy. A scholar is included among the top collaborators of Steven Bondy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven Bondy. Steven Bondy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Hebner, Christy M., Bin Han, Katherine M. Brendza, et al.. (2012). The HCV Non-Nucleoside Inhibitor Tegobuvir Utilizes a Novel Mechanism of Action to Inhibit NS5B Polymerase Function. PLoS ONE. 7(6). e39163–e39163. 32 indexed citations
2.
Vliegen, Inge, Jan Paeshuyse, I‐hung Shih, et al.. (2011). In Vitro Combination Therapy with Tegobuvir (GS-9190) is Highly Efficient in Curing Cells from HCV Replicon and in Delaying/Preventing the Development of Antiviral Resistance. Antiviral Research. 90(2). A65–A65. 1 indexed citations
3.
Vliegen, Inge, Jan Paeshuyse, Tine De Burghgraeve, et al.. (2009). Substituted imidazopyridines as potent inhibitors of HCV replication. Journal of Hepatology. 50(5). 999–1009. 35 indexed citations
4.
Bondy, Steven & Edward Sharman. (2007). Melatonin and the aging brain. Neurochemistry International. 50(4). 571–580. 38 indexed citations
5.
Vliegen, Inge, Jan Paeshuyse, Eric Mabery, et al.. (2007). GS-9190, a novel substituted imidazo-pyridine analogue, is a potent inhibitor of hepatitis C virus replication in vitro and remains active against known drug-resistant mutants. 8 indexed citations
6.
Vliegen, Inge, Jan Paeshuyse, Laura S. Lehman, et al.. (2007). Substituted Imidazopyridines as Potent Inhibitors of Hepatitis C Virus Replication that Target the Viral Polymerase. Antiviral Research. 74(3). A37–A37. 2 indexed citations
7.
Vliegen, Inge, Betty Peng, Hao Yang, et al.. (2007). Mechanistic characterization of GS-9190, a novel non-nucleoside inhibitor of HCV NS5B polymerase with potent antiviral activity and a unique mechanism of action. 12 indexed citations
8.
Lamb, Michelle L., Erin K. Bradley, Graham Beaton, et al.. (2004). Design of a gene family screening library targeting G-protein coupled receptors. Journal of Molecular Graphics and Modelling. 23(1). 15–21. 5 indexed citations
9.
Conley, Anthony J., Steven Bondy, John Hannah, et al.. (1994). Immunogenicity of synthetic HIV-1 gp120 V3-loop peptide-conjugate immunogens. Vaccine. 12(5). 445–451. 30 indexed citations
10.
Siciliano, Salvatore, Thomas E. Rollins, Julie A. DeMartino, et al.. (1994). Two-site binding of C5a by its receptor: analternative binding paradigm for G protein-coupled receptors.. Proceedings of the National Academy of Sciences. 91(4). 1214–1218. 201 indexed citations
11.
Keller, Paul M., Beth Arnold, Alan Shaw, et al.. (1993). Identification of HIV Vaccine Candidate Peptides by Screening Random Phage Epitope Libraries. Virology. 193(2). 709–716. 80 indexed citations
12.
Gammon, Maureen C., Maria A. Bednarek, William E. Biddison, et al.. (1992). Endogenous loading of HLA-A2 molecules with an analog of the influenza virus matrix protein-derived peptide and its inhibition by an exogenous peptide antagonist. The Journal of Immunology. 148(1). 7–12. 8 indexed citations
13.
Durette, Philippe L., Ihor E. Kopka, Thomas J. Lanza, et al.. (1992). The inhibition of C5a receptor binding by analogs of L-156,602, a cyclic hexadepsipeptide antibiotic. Bioorganic & Medicinal Chemistry Letters. 2(9). 1033–1038. 3 indexed citations
14.
Caldwell, Charles G. & Steven Bondy. (1990). A Convenient Synthesis of Enantiomerically Pure (2S,3S)- or (2R,3R)-3-Hydroxyleucine. Synthesis. 1990(1). 34–36. 55 indexed citations
15.
Caldwell, Charles G., et al.. (1990). Synthesis of the lipophilic side chain of the cyclic hexadepsipeptide antibiotic L-156,602. The Journal of Organic Chemistry. 55(8). 2355–2361. 28 indexed citations
16.
Durette, Philippe L., Peter L. Barker, Joshua Boger, et al.. (1990). Total synthesis of 1-156,602, a novel cyclic hexadepsipeptide antibiotic. Tetrahedron Letters. 31(9). 1237–1240. 37 indexed citations
17.
Bondy, Steven. (1986). The biochemical evaluation of neurotoxic damage. Fundamental and Applied Toxicology. 6(2). 208–216. 4 indexed citations
18.
Seth, P. K., Jau‐Shyong Hong, Clinton D. Kilts, & Steven Bondy. (1981). Alteration of cerebral neurotransmitter receptor function by exposure of rats to manganese. Toxicology Letters. 9(3). 247–254. 29 indexed citations
19.
Marangos, Paul J., et al.. (1975). Axoplasmic transport of a brain-specific soluble protein☆. Biochimica et Biophysica Acta (BBA) - General Subjects. 392(1). 75–81. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jeffrey S. Culp Breakdown of academic impact, for papers by Jean Vizzavona Breakdown of academic impact, for papers by David L. Earnshaw Breakdown of academic impact, for papers by Peggy Huang Breakdown of academic impact, for papers by Maria Chiara Nardi Breakdown of academic impact, for papers by Thomas Stangler Breakdown of academic impact, for papers by Carol A. Bannow Breakdown of academic impact, for papers by Michele Tinti Breakdown of academic impact, for papers by Michael D. Minnich Breakdown of academic impact, for papers by Abbas Rashidbaigi
Rankless by CCL
2026